Clinical Trials Browser

INDUSTRY × Metastatic Urothelial Cancer and Other Malignant Solid Tumors × enfortumab vedotin × Clear all

NCT02091999 2024-11-01

A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4

Phase 1 Completed

GenitourinaryOther solid neoplasm

Metastatic Urothelial Cancer and Other Malignant Solid Tumors